$ADAP Adaptimmune Therapeutics PLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Adaptimmune Therapeutics PLC. Insider overview, share value development, latest insider transactions and email notifications about new events in Adaptimmune Therapeutics PLC for free.

CIK Number: 0001621227
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ADAP
Company Address: 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE OX14 4RX
Phone number: 44 1235 430000
Former name: Adaptimmune Ltd, date of change: 2014-10-01

Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Market Capitalization: $321.36M
Prev close: $4.53
Average Daily Volume: 132,921
Days Low: $4.41
Year Low: $3.76
Year High: $11.59

Adaptimmune Therapeutics PLC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 28 2021ADAPAdaptimmune Therap ...Rawcliffe AdrianChief Executive Off ...SellS4.372,79412,2103,0585.9 K to 3.1 K (-47.74 %)
Mar 03 2021ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...BuyM0.161,785,000280,2451,800,00015 K to 1.8 M (+11,900.00 %)
Jan 19 2021ADAPAdaptimmune Therap ...Norry ElliotChief Medical Offic ...SellS5.672,11111,9683,5395.7 K to 3.5 K (-37.36 %)
Jan 19 2021ADAPAdaptimmune Therap ...Lunger JohnChief Patient Suppl ...SellS5.674,35824,7087,34611.7 K to 7.3 K (-37.24 %)
Jan 19 2021ADAPAdaptimmune Therap ...Rawcliffe AdrianChief Executive Off ...SellS5.679,87956,00913,52923.4 K to 13.5 K (-42.20 %)
Jan 12 2021ADAPAdaptimmune Therap ...Bertrand William C JRChief Operating Off ...SellS6.152,23413,7443,7686 K to 3.8 K (-37.22 %)
Jan 12 2021ADAPAdaptimmune Therap ...Lunger JohnChief Patient Suppl ...SellS6.151,0586,5091,7672.8 K to 1.8 K (-37.45 %)
Jan 12 2021ADAPAdaptimmune Therap ...Norry ElliotChief Medical Offic ...SellS6.158415,1741,3962.2 K to 1.4 K (-37.59 %)
Jan 12 2021ADAPAdaptimmune Therap ...Rawcliffe AdrianChief Executive Off ...SellS6.152,70716,6543,6956.4 K to 3.7 K (-42.28 %)
Jan 11 2021ADAPAdaptimmune Therap ...Wood GavinChief Financial Off ...Option ExerciseA0.00242,712340242,712
Jan 11 2021ADAPAdaptimmune Therap ...Wood GavinChief Financial Off ...Option ExerciseA1.031,086,8161,119,4201,086,816
Jan 11 2021ADAPAdaptimmune Therap ...Norry ElliotChief Medical Offic ...Option ExerciseA0.00242,712340242,712
Jan 11 2021ADAPAdaptimmune Therap ...Norry ElliotChief Medical Offic ...Option ExerciseA1.031,086,8161,119,4201,086,816
Jan 11 2021ADAPAdaptimmune Therap ...Rawcliffe AdrianChief Executive Off ...Option ExerciseA0.00728,1601,019728,160
Jan 11 2021ADAPAdaptimmune Therap ...Rawcliffe AdrianChief Executive Off ...Option ExerciseA1.033,260,4003,358,2123,260,400

View all Adaptimmune Therapeutics PLC insider transactions.